Uğur SELEK, Duygu SEZEN, Yasemin BÖLÜKBAŞI, Yücel SAĞLAM, Vildan ALPAN, Ali İhsan ATASOY, Nülifer KILIÇ DURANKUŞ

Case Presentation: The Effect of Volumetric Image Guidance & Adaptive Radiotherapy on Cardiac Dose in A Patient with Esophageal Cancer

We present the case of a patient with esophageal cancer whose tumor size regression prompted re-planning to decrease the cardiac dose. A 68-year-old male presented at our outpatient clinic with dysphagia.He was diagnosed with clinical T3N1M0 adenocarcinoma located at the distal esophagus–esophagogastric junction. He was decided to have surgery after receiving neoadjuvant chemoradiotherapy. Following4-D CT simulation, IG-IMRT with SIB technique was planned as 50 Gy in 25 fractions to iGTV and as45 Gy to the area identified as the CTV. Daily kV and weekly CBCT were planned at the beginning ofthe treatment. Concurrent CT with weekly paclitaxel–carboplatin was administered. At the simulationand start of the treatment, the heart was pushed anteriorly due to the mass effect and dilatation in themid-lower esophagus. The mass and dilatation regressed at the weekly CBCT of the patient. The thirdweek CBCT evaluation revealed the movement of the heart posteriorly into the PTV. Re-simulation wasperformed to continue with the adaptive planning for the last 10 treatment fractions. The cumulative dosereceived by the heart was reduced from 96% to 93% for V5Gy, from 79% to 60.8% for V10Gy, from 60%to 43.2% for V15Gy, from 35% to 21% for V20Gy, and from 29.6 to 28 Gy for the mean cardiac dose withthe volumetric image-guided adaptive planning. If tumor regression is predicted during radiotherapy topossibly change doses of organs at risk, volumetric image guidance should be encouraged once per week,at least, to consider adaptive treatment when required to ensure the critical organ doses within safe limits.

PDF

___

1. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al; CROSS Group. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 2012;366(22):2074–84.
2. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999;281(17):1623–7.
3. Tepper J, Krasna MJ, Niedzwiecki D, Hollis D, Reed CE, Goldberg R, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 2008;26(7):1086– 92.
4. Kole TP, Aghayere O, Kwah J, Yorke ED, Goodman KA. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer. Int J Radiat Oncol Biol Phys 2012;83(5):1580–6.
5. Münch S, Aichmeier S, Hapfelmeier A, Duma MN, Oechsner M, Feith M, et al. Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT. Strahlenther Onkol 2016;192(10):722–9.
6. Xu C, Xi M, Komaki R, Balter PA, Huang M, Hobbs BP, et al. Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagus. Adv Radiat Oncol 2017;2(3):325– 32.
7. Hu CY, Li JB, Wang JZ, Wang W, Li FX, Guo YL. Comparison of gross tumor volume of primary oesophageal cancer based on contrast-enhanced three-dimensional, four-dimensional, and cone beam computed tomography. Oncotarget 2017;8(56):95577–85.
8. Dieleman EM, Senan S, Vincent A, Lagerwaard FJ, Slotman BJ, van Sörnsen de Koste JR. Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration. Int J Radiat Oncol Biol Phys 2007;67(3):775–80.
9. Patel AA, Wolfgang JA, Niemierko A, Hong TS, Yock T, Choi NC. Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer. Int J Radiat Oncol Biol Phys 2009;74(1):290–6.
10.Vivekanandan N, Sriram P, Kumar SA, Bhuvaneswari N, Saranya K. Volumetric modulated arc radiotherapy for esophageal cancer. Med Dosim 2012;37(1):108–13.
11.Martins L, Couto JG, Barbosa B. Use of planar kV vs. CBCT in evaluation of setup errors in oesophagus carcinoma radiotherapy. Rep Pract Oncol Radiother 2016;21(1):57–62.
12.Yamashita H, Haga A, Hayakawa Y, Okuma K, Yoda K, Okano Y, et al. Patient setup error and day-to-day esophageal motion error analyzed by cone-beam computed tomography in radiation therapy. Acta Oncol 2010;49(4):485–90.
13.Cohen RJ, Paskalev K, Litwin S, Price RA Jr, Feigenberg SJ, Konski AA. Esophageal motion during radiotherapy: quantification and margin implications. Dis Esophagus 2010;23(6):473–9.
14.Hawkins MA, Brooks C, Hansen VN, Aitken A, Tait DM. Cone beam computed tomography-derived adaptive radiotherapy for radical treatment of esophageal cancer. Int J Radiat Oncol Biol Phys 2010;77(2):378– 83.
15.Sriram P, Syamkumar SA, Kumar JS, Prabakar S, Dhanabalan R, Vivekanandan N. Adaptive volumetric modulated arc treatment planning for esophageal cancers using cone beam computed tomography. Phys Med 2012;28(4):327–32.
16.Nyeng TB, Nordsmark M, Hoffmann L. Dosimetric evaluation of anatomical changes during treatment to identify criteria for adaptive radiotherapy in oesophageal cancer patients. Acta Oncol 2015;54(9):1467–73.
17.Wang J, Lin SH, Dong L, Balter P, Mohan R, Komaki R, et al. Quantifying the interfractional displacement of the gastroesophageal junction during radiation therapy for esophageal cancer. Int J Radiat Oncol Biol Phys 2012;83(2):e273–80.
18.Ramella S, Fiore M, Silipigni S, Zappa MC, Jaus M, Alberti AM, et al. Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC. J Thorac Oncol 2017;12(7):1122–30.

ISSN: 1300-7467
Yayın Aralığı: 4
Başlangıç: 2015
Yayıncı: Ali Cangül

Arşiv

Sayıdaki Diğer Makaleler

Prognostic Importance of Ki-67 Labeling Index in Grade II Glial Tumors

Meryem AKTAN, Gül KANYILMAZ, Eray KARAHACIOĞLU, Hatice ÖNDER, Hüseyin BORA, Mehmet KOÇ, Haldun Şükrü ERKAL, Eda YİRMİBEŞOĞLU ERKAL

Validity and Reliability of The Turkish Version of Fear of Cancer Recurrence Inventory

Aslı EYRENCİ, Hanife Özlem SERTEL BERK

Comparison of Three-Dimensional Conformal Radiation Therapy, Intensity-Modulated Radiation Therapy, and Volumetric-Modulated Arc Therapy In Glioblastoma Multiforme Radiation Therapy With EORTC Target Delineation

Musa ALTUN, Kamuran İBİŞ, Canan KÖKSAL, Uğur AKBAŞ

Case Presentation: The Effect of Volumetric Image Guidance & Adaptive Radiotherapy on Cardiac Dose in A Patient with Esophageal Cancer

Uğur SELEK, Duygu SEZEN, Yasemin BÖLÜKBAŞI, Yücel SAĞLAM, Vildan ALPAN, Ali İhsan ATASOY, Nülifer KILIÇ DURANKUŞ

Where Should Radiotherapy Stand in the Current era of Rectal Cancer Management?

Uğur SELEK, Duygu SEZEN, Yasemin BÖLÜKBAŞI, Nülifer KILIÇ DURANKUŞ

Mucinous Breast Carcinoma: A Single-Center Experience

Nilgün YILDIRIM, Mehmet Naci ALDEMİR